Hemo Organic Ltd (HEMORGANIC) is currently trading at 15.72 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Hemo Organic Ltd, formerly known as Dinesh Allorga Limited, produces and sells white coal, ayurvedic medicines, and chemicals in India. The company plans a strategic shift by entering the chemical manufacturing space with a new project near Khambhat, Gujarat. This project focuses on manufacturing 2.6 Di Chloro Aniline and Para Chloro Meta Cresol, crucial in pharmaceuticals and the leather industry respectively. The project involves a significant investment of Rs.447 lacs, aiming to expand the company's product offerings and market reach.

Over the past 52 weeks, Hemo Organic Ltd has traded between a low of ₹8.05 and a high of ₹22.51. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Hemo Organic Ltd has a market capitalization of approximately 5.56. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Hemo Organic Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 54.21 and operates in the Trading sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 5.56 Cr, Hemo Organic Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Hemo Organic Ltd operates in the Trading sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Hemo Organic Ltd is 54.21. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.